White paper
Mastering the complexities of targeted medicines
Targeted medicines are redefining modern healthcare by providing personalized therapies meticulously designed to address each patient’s unique disease profile. Given the early success of targeted medicines, such therapies hold great promise, but this often brings new complexities to navigate. Embark on a journey to master the complexities of targeted medicines in this white paper from Cencora.
White paper
Download now
This white paper presents considerations for planning, developing, and bringing to market targeted medicines with specific considerations for organizations to contemplate across key domains.
Key learning objectives:
- Understanding the regulatory landscape for targeted medicines
- Learning how biomarkers are used in treatment with a targeted therapy
- Discovering why companion diagnostics (CDx) are an indispensable tool in the field of targeted therapies
- Developing strategies to navigate the complexities of developing targeted medicines
